Novo Nordisk

Aktuelle Nachrichten

Schlagzeilen in der Originalsprache der Quelle.

• 
  Stocktwits Biotech Dealmaker — Novartis, Sanofi And Novo Sign Week’s Biggest Deals (öffnet in neuem Tab)

  03.10.2026

• 
  Novo Nordisk Holds Its 2026 Outlook As FDA Review Of Its Blood Disorder Drug Runs Long (öffnet in neuem Tab)

  02.10.2026

• 
  Anthropic Is Spending $100M To Build The AI Workforce It Needs For Its Next Phase (öffnet in neuem Tab)

  02.10.2026

• US FDA extends review of Novo Nordisk's hemophilia drug over facility issues (öffnet in neuem Tab)

  Reuters · 02.10.2026

• FDA extends review for Novo Nordisk's denecimig for hemophilia A (öffnet in neuem Tab)

  TradingView · 02.10.2026

• eli lilly and novo nordisk will discount their weight-loss drugs (öffnet in neuem Tab)

  BusinessWorld Online · 02.10.2026

• Novo provides update on the denecimig Biologics License Application (BLA) in the US (öffnet in neuem Tab)

  Yahoo Finance UK · 02.10.2026

• eli lilly and novo nordisk weight loss drugs (öffnet in neuem Tab)

  BusinessWorld Online · 02.10.2026

• novo nordisk glp 1 drugs for weight loss (öffnet in neuem Tab)

  BusinessWorld Online · 02.10.2026

• Novo Nordisk Strikes Nearly $4 Billion in 2 Deals. Here's What That Means for Investors (öffnet in neuem Tab)

  02.10.2026

• weight loss drug novo nordisk (öffnet in neuem Tab)

  BusinessWorld Online · 02.10.2026

• novo nordisk cuts cash prices for weight-loss drugs. (öffnet in neuem Tab)

  BusinessWorld Online · 02.10.2026

• novo nordisk drug study shows significant weight loss results (öffnet in neuem Tab)

  BusinessWorld Online · 02.10.2026

• novo nordisk weight loss drug news (öffnet in neuem Tab)

  BusinessWorld Online · 02.10.2026

• Novo Nordisk's Semaglutide Edges Out Tirzepatide on Heart Risk as Oral Wegovy Sheds Pounds in Real-W (öffnet in neuem Tab)

  AD HOC NEWS · 02.10.2026

• Novo Nordisk vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? (öffnet in neuem Tab)

  The Motley Fool · 02.10.2026

• novo nordisk is cutting prices on its weight loss drugs (öffnet in neuem Tab)

  BusinessWorld Online · 02.10.2026

• Novo Nordisk Tests Zenagamtide Dosing to Sharpen Its Obesity Drug Pipeline (öffnet in neuem Tab)

  TipRanks · 02.10.2026

• Novo Nordisk (NYSE: NVO) Wegovy Clears Liver Fat To Normal Levels In Nearly 9 Out Of 10 Obese Adults In STEP UP Trial Analysis (öffnet in neuem Tab)

  foreignpolicyjournal.com · 02.10.2026

• Novo Nordisk (CPSE:NOVO B) On New Wegovy Data And The Valuation Narrative (öffnet in neuem Tab)

  Yahoo Finance · 02.10.2026

• novo nordisk says obesity drug trial confirms weight loss (öffnet in neuem Tab)

  BusinessWorld Online · 02.10.2026

• novo nordisks new drug amycretin shows significant weight loss (öffnet in neuem Tab)

  BusinessWorld Online · 02.10.2026

• Novo Nordisk's Dual Data Drop: CagriSema Outperforms Tirzepatide as Oral Wegovy Holds Its Own (öffnet in neuem Tab)

  AD HOC NEWS · 02.10.2026

• novo nordisk sues hims & hers over copycat weight-loss drugs (öffnet in neuem Tab)

  BusinessWorld Online · 02.10.2026

• DXCM Report Highlights CGM Growth Opportunity in Type 2 Diabetes Care (öffnet in neuem Tab)

  02.10.2026

• novo nordisk weight loss drug wegovy approved in china (öffnet in neuem Tab)

  BusinessWorld Online · 02.10.2026

• Agios' Growth Story Hinges on Mitapivat's Commercial Expansion (öffnet in neuem Tab)

  02.10.2026

• Prediction: Eli Lilly Could Be the Next $2 Trillion Drugmaker (öffnet in neuem Tab)

  02.10.2026

• 3 drug targets pharma is betting on next (öffnet in neuem Tab)

  02.10.2026

• Novo Nordisk's Wegovy Pill Cuts Liver Fat in 88.5% of Patients as Shares Stay Stuck Near Yearly Lows (öffnet in neuem Tab)

  AD HOC NEWS · 02.10.2026